Related Experiment Video

Updated: May 11, 2026

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

[Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders]

, Daniel Podzamczer Palter, José A Muñoz-Moreno

    Enfermedades Infecciosas Y Microbiologia Clinica
    |May 7, 2013
    PubMed

    Insights

    This consensus document provides clinical recommendations for managing human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND). Early diagnosis and multidisciplinary management are crucial for improving quality of life in patients with HIV-associated neurocognitive disorder.

    Area of Science:

    • Neuroscience and Infectious Diseases
    • Clinical Management of HIV-Associated Neurocognitive Disorder (HAND)

    Background:

    • HIV-associated neurocognitive disorder (HAND) is highly prevalent and significantly impacts patients' quality of life and daily activities.
    • A growing incidence of HAND is anticipated, necessitating updated clinical management strategies.

    Framework:

    • A consensus document was developed by a multidisciplinary expert panel (GeSIDA and National AIDS Plan).
    • Recommendations are based on a comprehensive review of scientific literature up to October 2012.
    • Evidence levels (I-III) and recommendation strengths (A-C) were used, following Infectious Disease Society of America criteria.

    Implementation:

    • The document provides multiple clinical recommendations for managing HAND.
    • Includes two graphical algorithms to guide diagnostic and therapeutic strategies.
    • Emphasizes a multidisciplinary approach for comprehensive patient care.

    Implications:

    • Effective diagnostic and therapeutic management of HAND is essential.
    • Proactive and multidisciplinary care can mitigate the negative impacts of HAND on patients' lives.
    • This consensus document serves as a vital resource for clinicians managing HAND.
    Abstract

    Keywords:
    Antiretroviral treatmentHuman immunodeficiency virusNeurocognitive disordersTrastornos neurocognitivosTratamiento antirretroviralVirus de la inmunodeficiencia humana

    More Related Videos

    A Rat Model of EcoHIV Brain Infection08:48

    A Rat Model of EcoHIV Brain Infection

    Published on: January 21, 2021

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

    Published on: October 6, 2022

    Related Concept Videos

    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
    Alzheimer Disease l: Introduction01:29

    Alzheimer Disease l: Introduction

    Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Dementia l: Introduction01:22

    Dementia l: Introduction

    Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
    Alzheimer Disease ll: Pathophysiology01:23

    Alzheimer Disease ll: Pathophysiology

    Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...